National Guideline Clearinghouse | Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion.

full-text ►

National Guideline Clearinghouse | Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion.



National Institute for Health and Care Excellence (NICE)

Guideline Title Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion. Bibliographic Source(s) National Institute for Health and Care Excellence (NICE). Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion. London (UK): National Institute for Health and Care Excellence (NICE); 2014 Feb. 48 p. (Technology appraisal guidance; no. 305).  Guideline Status This is the current release of the guideline. This guideline meets NGC's 2013 (revised) inclusion criteria.